Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer
Antibodies against inhibitory immune checkpoint molecules (ICPMs), referred to as immune checkpoint inhibitors (ICIs), have gained a prominent place in cancer therapy. Several ICIs in clinical use have been engineered to be devoid of effector functions because of the fear that ICIs with preserved ef...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2021-04-01
|
| シリーズ: | Cells |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2073-4409/10/4/872 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|